Joseph E. Lehnen
Keine laufenden Positionen mehr
Profil
Joseph E.
Lehnen served as Chief Financial Officer at Perlegen Sciences, Inc., MaxCyte, Inc., and InforMax Software.
He was also President at Netchoicetv, Inc. and President-Investment Banking at J.P.
Morgan & Co. Ltd.
Prior to that, he worked as a Principal at Strategic Capital Consultants, Inc. Lehnen holds a graduate degree from Harvard University and a graduate degree from Yale University.
He also holds an undergraduate degree from Santa Clara University.
Ehemalige bekannte Positionen von Joseph E. Lehnen
| Unternehmen | Position | Ende |
|---|---|---|
| J.P. Morgan & Co. Ltd. | Corporate Officer/Principal | - |
| InforMax Software | Finanzdirektor/CFO | - |
| Strategic Capital Consultants, Inc. | Corporate Officer/Principal | - |
| Netchoicetv, Inc. | Präsident | - |
| MAXCYTE, INC. | Finanzdirektor/CFO | - |
Ausbildung von Joseph E. Lehnen
| Harvard University | Graduate Degree |
| Yale University | Graduate Degree |
| Santa Clara University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
| Netchoicetv, Inc. | |
| Strategic Capital Consultants, Inc. | |
| InforMax Software | |
| J.P. Morgan & Co. Ltd. | Finance |
